Biofrontera AG provided preliminary revenue guidance for the full year ending December 31, 2021. For the year, the company expects revenue to be in the range of EUR 28.7 million to EUR 28.9 million compared to EUR 30.3 million in 2020.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.51 EUR | -1.40% | -48.41% | -58.32% |
May. 15 | Earnings Flash (BFRI) BIOFRONTERA Reports Q1 Revenue $7.9M, vs. Street Est of $10.9M | MT |
Apr. 30 | Biofrontera AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-58.32% | 11.45M | |
+34.35% | 705B | |
+31.04% | 583B | |
-3.49% | 364B | |
+20.15% | 332B | |
+6.19% | 291B | |
+15.13% | 238B | |
-3.76% | 210B | |
+10.12% | 209B | |
+9.21% | 169B |
- Stock Market
- Equities
- B8FK Stock
- News Biofrontera AG
- Biofrontera AG Provides Preliminary Revenue Guidance for the Full Year Ending December 31, 2021